Items 61 ~ 80 of 5552, Page 4 of 279 
  04/13/2019 WHO - Public Health
At WHO Forum on Medicines, countries and civil society push for greater transparency and fairer prices
- WHO to continue to facilitate countries' information-sharing to improve transparency on prices
  04/11/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
FDA orders important safety labeling changes for Addyi
  04/03/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
Statement on FDA’s continued efforts to stop stem cell clinics and manufacturers from marketing unapproved products that put patients at risk, while progressing the agency’s commitment to help advance legitimate stem cell product development under existing agency regulations
  04/03/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
Statement on FDA’s ongoing scientific investigation of potential safety issue related to seizures reported following e-cigarette use, particularly in youth and young adults
  04/02/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
Statement on steps toward a new, tailored review framework for artificial intelligence-based medical devices
  04/02/2019 Radiological Society of North America - Clinical
Bariatric Embolization Shows Promise in Treatment of Obesity
- Bariatric embolization, a new, minimally invasive treatment for obesity produces weight loss and reduces appetite for up to one year, according to a new study published in the journal Radiology.
  04/01/2019 MERCK - Business
Selumetinib Granted U.S. Breakthrough Therapy Designation in Neurofibromatosis Type 1
- Designation Based on Phase 2 SPRINT Trial in Pediatric Patients with NF1 Plexiform Neurofibromas / Selumetinib Is a MEK 1/2 Inhibitor Being Co-Developed by AstraZeneca and Merck
  03/29/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
FDA approves new oral treatment for multiple sclerosis
  03/27/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
FDA advances landmark policy changes to modernize mammography services and improve their quality
- Proposed rule would require breast density reporting, enhance the FDA’s ability to enforce mammography facilities’ compliance with standards
  03/26/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
FDA approves new oral drug to treat multiple sclerosis

<<  <  [1]  [2]  [3]  [4[5]  [6]  [7]  [8]  [9]  [10]  >  >>
Go to Headlines